GlassScriptPhysician profile
Lee A Kripke
NPI 1063907004
$21,074.67
in general payments reported to CMS, 2019-2025
21 companies · $495 in 2025
The $495 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $124 · 2021: $353 · 2022: $1,297 · 2023: $15K · 2024: $2,820 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $3,521 · Travel and Lodging: $2,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $3,521.22 |
| Travel and Lodging | $2,674.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $12,500.00 | 2023 | |
| Alphatec Spine, INC | $1,754.71 | 2023-2024 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $1,578.87 | 2019-2023 | Persona |
| Depuy Synthes Sales INC. | $939.35 | 2019-2024 | Symphony, Attune, Viper |
| Synthes Gmbh | $825.10 | 2023 | |
| Medtronic, INC. | $801.14 | 2023-2024 | Mazor X System, Clydesdale Ptc Spinal System |
| Stryker Corporation | $717.70 | 2021-2025 | Insignia, Mako, Augment Injectable |
| Nuvasive Specialized Orthopedics, INC. | $250.52 | 2019-2022 | |
| Cerapedics INC. | $230.80 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Integra Lifesciences Corporation | $207.54 | 2019 | |
| Si-Bone, INC. | $198.85 | 2023 | |
| Medshape, INC. | $162.11 | 2023 | Dynanail, Dynanail Helix, Washer, 15 Mm, Dynanail Hybrid |
| Globus Medical, INC. | $154.05 | 2024-2025 | Xlif, Colonial / Colonial Tps, Resonate |
| Smith+Nephew, INC. | $148.71 | 2023 | Anthology |
| Vb Spine LLC | $143.88 | 2025 | Mako Spine |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $124.08 | 2024 | Zynrelef |
| Kuros Biosciences USA, INC | $123.70 | 2023 | |
| Carlsmed, INC. | $74.65 | 2024 | Aprevo |
| Novus Surgical Consultants | $60.88 | 2025 | |
| Axogen | $60.18 | 2022 | |
| Medical Device Business Services, INC. | $17.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Kripke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.